The largest database of trusted experimental protocols

9 protocols using ag490

1

Alcoholic Hepatitis Murine Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
At days 3, 6, and 11 of the modeling period, mice in the AH groups were gavaged a single dose of ethanol (31.5% ethanol(v/v), 400 μl/mouse), while mice in the control group were gavaged isocaloric dextrin maltose (45%(w/v), 400 μl/mouse). At day 10, MSCs with or without transfection were intraperitoneally (i.p.) administered to the AH+MSCs, AH+sc-MSCs, AH+siTSG-6-MSCs, and AH+MSCs+AG490 groups (5 × 106 cells/mouse); following injection of MSCs, an additional dose of AG490 (Tocris, Bristol, UK) was given to the AH+MSCs+AG490 group (20 μg/mouse, i.p.); rmTSG-6 (R&D, Minneapolis, MN, USA) was injected to the AH+rmTSG-6 group (10 μg/mouse, i.p.); equal volumes of saline were administered to the control or AH group per protocol requirement. The gavage was always performed in the morning, and mice were then maintained on control or ethanol diet. After ethanol gavage, mice were lethargic and tachypneic, but they recovered within 4–6 h. The mice were always anesthetized 9 h post the last gavage with samples of blood, peritoneal fluid lavage, and liver tissues harvested for further analyses (Additional file 1).
+ Open protocol
+ Expand
2

Molecular Mechanisms Regulating Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dulbecco’s modified Eagles’ medium (DMEM), penicillin/streptomycin, trypsin/EDTA, fetal bovine serum (FBS), KGM-SFM medium, and phosphate-buffered saline (PBS) were from Gibco (Life Technologies, USA). Arecoline, melatonin and MTT were from Sigma (Sigma-Aldrich Chemical Company, St. Louis, MO, USA). ELISA kits for MMP-9 were from PeproTech (PeproTech, Inc., Rocky Hill, NJ, USA). Catalase, SB431542, 5Z-7-Oxozeaenol, PD153035, AG490, U0126, LY294002, and aspirin were purchased from Tocris. Phospho-TAK1 (p-TAK1) antibody was from Abcam (ab79583). Antibodies for TGF-β1, and GAPDH were from Santa Cruz. P-Smad2 antibody was from Cell Signaling Technology. PBL extract and ANE were prepared as before [8 (link), 12 (link), 13 (link), 21 (link)]. HC was synthesized as previously [22 (link)].
+ Open protocol
+ Expand
3

Cell Culture and Signaling Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs were cultured in EBM2+ BulletKit (cells and media from Lonza, Rockville, MD). CHO-K1 cells were obtained from the American Type Culture Collection (Manassas, VA) and grown in high-glucose DMEM supplemented with 10% fetal bovine serum and antibiotic–antimycotic solution (all from Life Technologies/ThermoFisher Scientific, Grand Island, NY). Y-27632 (ROCK inhibitor) was purchased from Millipore (Billerica, MA). Cell-permeable C3 (RhoA inhibitor) transferase was purchased from Cytoskeleton (Denver, CO). U0126 (MEK inhibitor), LY294002 (PI3K inhibitor), Su6656 (Src family kinase inhibitor), AG 490 (JAK2 inhibitor), Gö6976 (PKCα inhibitor), FAK inhibitor 14, and PKCζ pseudosubstrate were from Tocris (Minneapolis, MN). All other reagents were from Sigma-Aldrich (St. Louis, MO) unless otherwise noted.
+ Open protocol
+ Expand
4

Immune Cell Profiling by Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
For flow cytometry and sorting experiments, antibodies to CD4 (RM4-4), NK1.1 (PK136), CD49b (DX5), CD3 (17A2), Ly6G (1A8), B220 (RA3-6B2), CD11c (N418), CD45.2 (104), CD45.1 (A20), CX3CR1 (SA011F11), IAb (AF6-120.1), CD11b (Mac1), CD90 (G7), lineage markers (17A2/RB6-8C5/RA3-6B2/Ter-119/M1/70), and CD127 (A7R34) were purchased from BioLegend. To stimulate neutrophils in vitro and for in vivo administration, we used either recombinant mouse IFN-λ2 (purchased from Peprotech) or recombinant mouse IFN-λ2 to which polyethylene glycol was attached (provided by Bristol-Myers Squibb). Recombinant mouse IFN-β was purchased from PBL interferonsource. Recombinant human IFN-λ2 and IFN-β were purchased from Peprotech. Puromycin was purchased from Sigma. Where indicated, specific chemical inhibitors were used. To inhibit protein synthesis, cycloheximide (Sigma) was used at a concentration of 10 μg/ml. To inhibit Jak signaling, pyridone 6 (BioVision) was used. To inhibit STAT-1 signaling, fludarabine (Tocris) was used. To inhibit Jak2 signaling, either AG490 (Tocris) or 1,2,3,4,5,6-hexabromocyclohexane (HBC, Tocris) was used. To stimulate neutrophils, either E. coli LPS (Serotype O55:B5 TLR grade, purchased from Enzo) or recombinant mouse TNF (Peprotech) was used.
+ Open protocol
+ Expand
5

Leptin Signaling in Mouse HSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mouse HSC line (GRX) was maintained in DMEM, 5% FBS, and 1% penicillin/streptomycin as described [27 (link)]. Cells were treated with recombinant leptin (100 ng/ml; R&D systems, Minneapolis, MN) for 48 h. For neutralization of OPN, 40% confluent cells were treated with OPN-specific aptamers or biologically-inactive mutant sham aptamers (6.66 µg/ml). For PI3K inhibition, LY294002 (25 µM; Cell Signalling Technology, Danvers, MA) was applied to cells 30 min prior to treatment. AG490 (50 µM; Tocris Biosciences, Ellisville, MO) was used to inhibit JAK signaling [19 ].
+ Open protocol
+ Expand
6

Molecular Signaling in Alzheimer's Disease

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-iNOS, anti-COX-2, anti-P-STAT3 (Tyr 705), anti-JAK2 and anti-P-JAK2 (Tyr1007/1008) antibodies were obtained from Cell Signaling (Danvers, MA). Anti-BACE1, anti-STAT3, anti-NF-κB p65, anti-IκBα, anti-SIRT1, and anti-histone H1 antibodies were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA). Anti-Aβ (6E10) anti-body was from Covance (Emeryville, CA). AG490 was from Tocris Bioscience (Bristol, UK). BAY11-7082, sirtinol, and quercetin were from Sigma-Aldrich (St. Louis, MO). Aβ1–42 peptide was purchased from AnaSpec (Fremont, CA). Taxifolin and cilostazol were donated by Otsuka Pharmaceutical Co. Ltd. (Tokushima, Japan).
+ Open protocol
+ Expand
7

Keratinocyte Growth and Inflammation Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Keratinocyte growth medium (KGM-SFM), pituitary gland extract and EGF were purchased from Gibco (Life Technologies, BRL, Grand Island, NY, USA). Arecoline, catalase, aspirin and 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) were obtained from Sigma (Sigma Chemical Company, St. Louis, MO, USA). ANE was prepared and weighed as previously described [25 (link), 32 (link)]. PGE2 and 8-isoprostane (8-iso-PGF) Enzyme-linked immunosorbant assay (ELISA) kits were obtained from Cayman Chemical Company (Ann Arbor, MI, USA). Human IL-1α ELISA kits were from PeproTech (Rocky Hill, NJ, USA), whereas ADAM17 and EGF ELISA kits were from R&D Systems (Minneapolis, MN, USA). GM6001, PD153035, AG490, pp2, U0126, α-naphthoflavone and ZnPP were obtained from Tocris or Cayman. Anti-EGF, anti-IL-1α and anti-TNFα neutralizing aby were obtained from PeproTech. Antibodies against COX-2, cdc2, ADAM9 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were from Santa Cruz, whereas antibodies for cytokeratin 5 and cytokeratin 14 were from GeneTex (GeneTex International Corporation, Global, Hsin-Chu, Taiwan). IRAK-1/4 inhibitor was from APExBIO (Houston, TX, USA).
+ Open protocol
+ Expand
8

Sheep Prolactin Electrophysiology Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sheep PRL and picrotoxin (PTX) were purchased from Sigma (St Louis, MO) and AG490 from Tocris Cookson (Bristol, UK). Drugs were prepared as stock solutions, stored frozen in the dark, and diluted to final concentration immediately before use. Sheep PRL (44.5 μM) was prepared in milli‐Q water while AG490 (100 mM) and 17β‐estradiol (50 mg/ml) were prepared in dimethyl sulfoxide and dissolved in sesame oil for s.c. injection. Drugs were dissolved in oxygenated aCSF at the desired concentration immediately before use. Slices were incubated (20 min) in sheep PRL before being transferred to the immersion chamber, in which PRL was present for the entire recording period at the same concentration.
+ Open protocol
+ Expand
9

JAK2 Inhibition Regulates IL-6-Induced Feeding

Check if the same lab product or an alternative is used in the 5 most similar protocols
ICV injection of AG490 (50 mM) (cat #0414, Tocris Bioscience, Bristol, United Kingdom) was used to inhibit JAK2 as previously described (Damm et al., 2013 (link); Quaresma et al., 2017 (link)). ICV injection of AG490 or its vehicle was performed twice daily in the afternoon; 30 min later, we injected IL-6 ICV before the lights were turned off. Food intake measurements or euthanasia started after 06:30 p.m. (dark cycle). For this experiment, we used wt/wt mice (6–8 weeks of age) obtained from the B6-tub/tub mouse colony.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!